Introduction: What is Crizanlizumab?
Crizanlizumab is a monoclonal antibody medication primarily used to treat sickle cell disease (SCD). It is designed to reduce the frequency of vasoocclusive crises, which are painful episodes caused by the blockage of blood vessels due to sickled red blood cells. By targeting specific molecules in the body, Crizanlizumab helps improve blood flow and reduce complications associated with this chronic condition.
Best Hospital Near me Chennai